Literature DB >> 6196309

Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125.

S E Kabawat, R C Bast, A K Bhan, W R Welch, R C Knapp, R B Colvin.   

Abstract

OC125, a murine monoclonal antibody, recognizes an antigenic determinant (CA125) that is associated with greater than 80% of epithelial ovarian neoplasms of serous, endometrioid, clear cell, and undifferentiated types. In the present report, a sensitive biotin-avidin immunoperoxidase technique was used to determine reactivity of OC125 with normal adult and fetal tissues, as well as with neoplasms of nonovarian origin. In fetal tissues, the antibody reacted with amnion and with derivatives of the coelomic epithelium, i.e., the müllerian epithelium and the lining cells of the peritoneum, pleura, and pericardium. Among adult tissues, OC125 reacted with the epithelium of fallopian tubes, endometrium, and endocervix. The CA125 determinant was also detected on mesothelial cells in the adult pleura, pericardium, and peritoneum, particularly in areas of inflammation and adhesion. Curiously, the surface epithelium of normal fetal and adult ovaries, thought to be derived from coelomic epithelium, did not express the determinant, except in inclusion cysts, areas of metaplasia, and papillary excrescences. Of neoplastic tissues of nonovarian origin, OC125 reacted consistently only with adenocarcinomas of the endocervix, endometrium, and fallopian tube, and with mesotheliomas. Only seven of 64 nongynecological tumors tested reacted with OC125. Thus, OC125 detects a differentiation antigen shared by fetal coelomic epithelium and its derivatives in the fetus and the adult. Apparently, this antigen disappears early in the course of formation of the ovarian epithelium and is reexpressed in certain reactive and neoplastic lesions, a process that could be termed "molecular metaplasia."

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6196309     DOI: 10.1097/00004347-198303000-00005

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  92 in total

1.  Re: Cancer antigen 125 as a biomarker in peritoneal dialysis: mesothelial cell health or death?

Authors:  J M Bargman
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

2.  Metaplastic changes in cultured human ovarian surface epithelium.

Authors:  A S Wong; P C Leung; S L Maines-Bandiera; N Auersperg
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-10       Impact factor: 2.416

3.  Postmenopausal Meigs' Syndrome in Elevated CA-125: A Case Report.

Authors:  Jung-Woo Park; Jong Woon Bae
Journal:  J Menopausal Med       Date:  2015-04-27

4.  Monoclonal antibodies against native ovarian tumor cells: specificity and characterization of the antigen. A preliminary report.

Authors:  L Wasserman; A Neri; B Kaplan; Y Manor; M Galli; B Hardy
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

5.  Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes.

Authors:  Jennifer A Belisle; Sachi Horibata; Gubbels A A Jennifer; Sarah Petrie; Arvinder Kapur; Sabine André; Hans-Joachim Gabius; Claudine Rancourt; Joseph Connor; James C Paulson; Manish S Patankar
Journal:  Mol Cancer       Date:  2010-05-24       Impact factor: 27.401

6.  LETTER TO THE EDITOR: Is the Determination of CA-125 Serum Levels Useful for the Diagnosis of Pulmonary Tuberculosis?

Authors:  Julio Collazos
Journal:  Open Respir Med J       Date:  2010-03-19

7.  Ovarian cancer pathogenesis: a model in evolution.

Authors:  Alison M Karst; Ronny Drapkin
Journal:  J Oncol       Date:  2009-09-06       Impact factor: 4.375

8.  CA 125 secretion by peritoneal mesothelial cells.

Authors:  A M Zeillemaker; H A Verbrugh; A A Hoynck van Papendrecht; P Leguit
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

9.  CA125/MUC16 is dispensable for mouse development and reproduction.

Authors:  Dong-Joo Cheon; Ying Wang; Jian Min Deng; Zhen Lu; Lianchun Xiao; Chun-Ming Chen; Robert C Bast; Richard R Behringer
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

10.  Meigs' Syndrome with Elevated Serum CA125: Case Report and Review of the Literature.

Authors:  Mongkol Benjapibal; Suthi Sangkarat; Somsak Laiwejpithaya; Boonlert Viriyapak; Pattama Chaopotong; Atthapon Jaishuen
Journal:  Case Rep Oncol       Date:  2009-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.